| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Proceeds from atm equity offering | - | 34,034 |
| Proceeds from issuance of common stock-At Market Offerings | 34,035 | - |
| Net cash provided by financing activities | 220,911 | 31,610 |
| Effect of exchange rates on cash | 23 | -281 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | -36,852 | 46,512 |
| Cash and cash equivalents at beginning of period | 89,601 | - |
| Cash and cash equivalents at end of period | 52,749 | - |
RHYTHM PHARMACEUTICALS, INC. (RYTM)
RHYTHM PHARMACEUTICALS, INC. (RYTM)